Z. Chen, H. Xie, M. Hu, T. Huang, Y. Hu, N. Sang, Y. Zhao, Recent progress in treatment of hepatocellular carcinoma. Am. J. Cancer Res. 10, 2993–3036 (2020)
CAS PubMed PubMed Central Google Scholar
T. Otto, P. Sicinski, Cell cycle proteins as promising targets in cancer therapy. Nat. Rev. Cancer 17, 93–115 (2017)
Article CAS PubMed PubMed Central Google Scholar
A. Jindal, A. Thadi, K. Shailubhai, Hepatocellular Carcinoma: Etiology and Current and Future Drugs. J. Clin. Exp. Hepatol. 9, 221–232 (2019)
Article PubMed PubMed Central Google Scholar
X. Qing, W. Xu, J. Zong, X. Du, H. Peng, Y. Zhang, Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomark. Res 9, 64 (2021)
Article PubMed PubMed Central Google Scholar
M. Malumbres, M. Barbacid, Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153–166 (2009)
Article CAS PubMed Google Scholar
R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, M. Urashima, K.T. Mc Henry, R.M. Pinchback, A.H. Ligon, Y.-J. Cho, L. Haery, H. Greulich, M. Reich, W. Winckler, M.S. Lawrence, B.A. Weir, K.E. Tanaka, D.Y. Chiang, A.J. Bass, A. Loo, C. Hoffman, J. Prensner, T. Liefeld, Q. Gao, D. Yecies, S. Signoretti, E. Maher, F.J. Kaye, H. Sasaki, J.E. Tepper, J.A. Fletcher, J. Tabernero, J. Baselga, M.-S. Tsao, F. Demichelis, M.A. Rubin, P.A. Janne, M.J. Daly, C. Nucera, R.L. Levine, B.L. Ebert, S. Gabriel, A.K. Rustgi, C.R. Antonescu, M. Ladanyi, A. Letai, L.A. Garraway, M. Loda, D.G. Beer, L.D. True, A. Okamoto, S.L. Pomeroy, S. Singer, T.R. Golub, E.S. Lander, G. Getz, Sellers, W. R., and Meyerson, M. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899–905 (2010)
S. Akli, C.S. Van Pelt, T. Bui, L. Meijer, K. Keyomarsi, Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of Cyclin E. Cancer Res. 71, 3377–3386 (2011)
Article CAS PubMed PubMed Central Google Scholar
Y. Hoshida, S.M. Nijman, M. Kobayashi, J.A. Chan, J.P. Brunet, D.Y. Chiang, A. Villanueva, P. Newell, K. Ikeda, M. Hashimoto, G. Watanabe, S. Gabriel, S.L. Friedman, H. Kumada, J.M. Llovet, T.R. Golub, Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 69, 7385–7392 (2009)
Article CAS PubMed PubMed Central Google Scholar
S. Rebouissou, J.C. Nault, Advances in molecular classification and precision oncology in hepatocellular carcinoma. J. Hepatol. 72, 215–229 (2020)
Article CAS PubMed Google Scholar
K. Schulze, J.C. Nault, A. Villanueva, Genetic profiling of hepatocellular carcinoma using next-generation sequencing. J. Hepatol. 65, 1031–1042 (2016)
Article CAS PubMed Google Scholar
W.F. Baron, C.Q. Pan, S.A. Spencer, A.M. Ryan, R.A. Lazarus, K.P. Baker, Cloning and characterization of an actin-resistant DNase I-like endonuclease secreted by macrophages. Gene 215, 291–301 (1998)
Article CAS PubMed Google Scholar
M. Napirei, S. Ludwig, J. Mezrhab, T. Klöckl, H.G. Mannherz, Murine serum nucleases - contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 276, 1059–1073 (2009)
Article CAS PubMed Google Scholar
A. Wilber, M. Lu, M.C. Schneider, Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection. Mol. Ther. 6, 35–42 (2002)
Article CAS PubMed Google Scholar
V. Sisirak, B. Sally, V. D’Agati, W. Martinez-Ortiz, Z.B. Ozcakar, J. David, A. Rashidfarrokhi, A. Yeste, C. Panea, A.S. Chida, M. Bogunovic, I.I. Ivanov, F.J. Quintana, I. Sanz, K.B. Elkon, M. Tekin, F. Yalcinkaya, T.J. Cardozo, R.M. Clancy, J.P. Buyon, B. Reizis, Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 166, 88–101 (2016)
Article CAS PubMed PubMed Central Google Scholar
P.S. Tsou, A.H. Sawalha, Unfolding the pathogenesis of scleroderma through genomics and epigenomics. J. Autoimmun. 83, 73–94 (2017)
Article CAS PubMed PubMed Central Google Scholar
M. Jiménez-Alcázar, C. Rangaswamy, R. Panda, J. Bitterling, Y.J. Simsek, A.T. Long, R. Bilyy, V. Krenn, C. Renné, T. Renné, S. Kluge, U. Panzer, R. Mizuta, H.G. Mannherz, D. Kitamura, M. Herrmann, M. Napirei, T.A. Fuchs, Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science 358, 1202–1206 (2017)
Z. Deng, M. Xiao, D. Du, N. Luo, D. Liu, T. Liu, D. Lian, J. Peng, DNASE1L3 as a prognostic biomarker associated with immune cell infiltration in cancer. Onco Targets Ther 14, 2003–2017 (2021)
Article PubMed PubMed Central Google Scholar
J. Liu, J. Yi, Z. Zhang, D. Cao, L. Li, Y. Yao, Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer. Aging (Albany NY) 13, 16513–16526 (2021)
S. Wang, H. Ma, X. Li, X. Mo, H. Zhang, L. Yang, Y. Deng, Y. Yan, G. Yang, X. Liu, H. Sun, DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection. Aging (Albany NY) 12, 1171–1185 (2020)
D. Guo, D. Ma, P. Liu, J. Lan, Z. Liu, Q. Liu, DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress. Aging (Albany NY) 13, 9874–9899 (2021)
M. Wang, T. Zhang, X. Zhang, Z. Jiang, M. Peng, Z. Huang, BMP2K dysregulation promotes abnormal megakaryopoiesis in acute megakaryoblastic leukemia. Cell. Biosci. 10, 57 (2020)
Article CAS PubMed PubMed Central Google Scholar
Z. Huang, T.D. Richmond, A.G. Muntean, D.L. Barber, M.J. Weiss, J.D. Crispino, STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J. Clin. Invest. 117, 3890–3899 (2007)
Article CAS PubMed PubMed Central Google Scholar
C. Ho, C. Wang, S. Mattu, G. Destefanis, S. Ladu, S. Delogu, J. Armbruster, L. Fan, S.A. Lee, L. Jiang, F. Dombrowski, M. Evert, X. Chen, D.F. Calvisi, AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2. Hepatology 55, 833–845 (2012)
Article CAS PubMed Google Scholar
J.K. Stauffer, A.J. Scarzello, J.B. Andersen, R.L. De Kluyver, T.C. Back, J.M. Weiss, S.S. Thorgeirsson, R.H. Wiltrout, Coactivation of AKT and β-Catenin in mice rapidly induces formation of lipogenic liver tumors. Cancer Res. 71, 2718–2727 (2011)
Article CAS PubMed PubMed Central Google Scholar
B.A. Diwan, J.M. Rice, J.M. Ward, Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice. Prog Clin. Biol. Res. 331, 69–83 (1990)
T. Uehara, G.R. Ainslie, K. Kutanzi, I.P. Pogribny, L. Muskhelishvili, T. Izawa, J. Yamate, O. Kosyk, S. Shymonyak, B.U. Bradford, G.A. Boorman, R. Bataller, I. Rusyn, Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis. Toxicol. Sci. 132, 53–63 (2013)
Article CAS PubMed PubMed Central Google Scholar
L.N. Coke, H. Wen, M. Comeau, M.H. Ghanem, A. Shih, C.N. Metz, W. Li, C.D. Langefeld, P.K. Gregersen, K.R. Simpfendorfer, Arg206Cys substitution in DNASE1L3 causes a defect in DNASE1L3 protein secretion that confers risk of systemic lupus erythematosus. Ann. Rheum. Dis. 80, 782–787 (2021)
Article CAS PubMed Google Scholar
M. Malumbres, M. Barbacid, To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222–231 (2001)
Article CAS PubMed Google Scholar
S.A. Ezhevsky, A. Ho, M. Becker-Hapak, P.K. Davis, S.F. Dowdy, Differential regulation of retinoblastoma tumor suppressor protein by g1 cyclin-dependent kinase complexes in vivo. Mol. Cell. Biol. 21, 4773–4784 (2001)
Article CAS PubMed PubMed Central Google Scholar
S. Campaner, M. Doni, P. Hydbring, A. Verrecchia, L. Bianchi, D. Sardella, T. Schleker, D. Perna, S. Tronnersjo, M. Murga, O. Fernandez-Capetillo, M. Barbacid, L.G. Larsson, B. Amati, Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat. Cell. Biol. 12, 54–59 (2010)
Article CAS PubMed Google Scholar
J. Du, H.R. Widlund, M.A. Horstmann, S. Ramaswamy, K. Ross, W.E. Huber, E.K. Nishimura, T.R. Golub, D.E. Fisher, Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell. 6, 565–576 (2004)
Article CAS PubMed Google Scholar
D. Ray, Y. Terao, K. Christov, P. Kaldis, H. Kiyokawa, Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis. Neoplasia 13, 439–444 (2011)
Article CAS PubMed PubMed Central Google Scholar
A.S. Tin, S.N. Sundar, K.Q. Tran, A.H. Park, K.M. Poindexter, G.L. Firestone, Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes. Anticancer Drugs 23, 370–379 (2012)
Article CAS PubMed Google Scholar
M. Ueki, H. Takeshita, J. Fujihara, R. Iida, I. Yuasa, H. Kato, A. Panduro, T. Nakajima, Y. Kominato, T. Yasuda, Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme. Clin. Chim. Acta 407, 20–24 (2009)
留言 (0)